Part 2: Pharmacogenetic Variability in Drug Transport and Phase I Anticancer Drug Metabolism

Equivalent drug doses in anticancer chemotherapy may lead to wide interpatient variability in drug response reflected by differences in treatment response or in severity of adverse drug reactions. Differences in the pharmacokinetic (PK) and pharmacodynamic (PD) behavior of a drug contribute to varia...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Deenen, Maarten J., Cats, Annemieke, Beijnen, Jos H., Schellens, Jan H.M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AlphaMed Press 2011
Gaiak:
Clinical Pharmacology: Pharmacogenetics: Opportunities for Patient-Tailored Anticancer Therapy
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228220/
https://ncbi.nlm.nih.gov/pubmed/21632461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0259
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak